EMEA
EMEA
The only online source for all FDA documentation, PharmaPendium also offers you access to the European Medicines Agency’s (EMEA) European Public Assessment Reports (EPARs).
Covering approximately 80,000 pages of searchable documents for EMEA approved drugs from 1995 to the present day, and more than 300 active ingredients approved for the European market - some not approved in US - PharmaPendium is the definitive source of drug information.
The EMEA EPAR documents provide critical data on:
- Efficacy
- Indications and dosage
- Safety
- Pharmacokinetics
- Pharmacology and mode of action
- Preclinical and clinical toxicity (extracted from documents)Adverse effects (extracted from documents)
- General product information Providing real insights into the differences between the USFDA and EMEA decision making process, you can rest assured that you’re as informed as possible.
PharmaPendium. Make informed drug development decisions.
Interested? Contact us today to find out more about how PharmaPendium could benefit you.